LIPIDOS

ENSAYOS CLINICOS


ENSAYOS CLINICOS

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction The IDEAL Study: A Randomized Controlled Trial (RESUMEN)
REVISTA: JAMA

Intensive lipid lowering with atorvastatin in patients with stable coronary disease (TNT study. Critically Appraised Trials
REVISTA: National Electronic Library

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid-Lowering Arm (ASCOT-LLA)
REVISTA: Diabetes Care

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease (TNT)
REVISTA: NEJM

CARDS: Rapid Appraisal
REVISTA: Regional Drug and Therapeutics

Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes Phase Z of the A to Z Trial
REVISTA: JAMA

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial (Resumen)
REVISTA: Lancet

PROVE-IT (Rapid Appraisal)
REVISTA: Regional Drug and Therapeutics

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomis
REVISTA: Lancet

Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention (LIPS) (Abstract)
REVISTA: JAMA

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial.
REVISTA: Lancet

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (texto completo)
REVISTA: Lancet

Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT) (texto competo)
REVISTA: JAMA